BRIEF-Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln

Reuters
19 Nov 2024
BRIEF-Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln

Nov 19 (Reuters) - Resonance Health Ltd RHT.AX:

  • RESONANCE CONTRACTED FOR CLINICAL DRUG TRIAL WORTH $13.775 MILLION

  • UNIT WILL SERVE AS CRO AND LOCAL (AUSTRALIAN) SPONSOR FOR CUSTOMER AND WILL ENGAGE AND MAKE PAYMENT TO INSTITUTIONS, OTHERS

  • ALL FIGURES IN AUD

Further company coverage: RHT.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10